Improved Delivery of Anticancer Drugs in Liposomes

  • ChemPubSoc Europe Logo
  • Author: ChemistryOpen
  • Published Date: 06 July 2018
  • Source / Publisher: ChemistryOpen/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Improved Delivery of Anticancer Drugs in Liposomes

Related Societies

Temoporfin is a drug used to treat cancer in photodynamic therapy. It is hydrophobic and, thus, aggregates when it is administered intravenously. This lowers the efficacy of the drug. One way to improve the efficacy is to use liposomal formulations, which avoid aggregation by encapsulating the drug in a vesicle with a hydrophilic outer surface. The success depends on the interactions which are responsible for the vesicle loading capacity and regulate the delivery to the tumor cells.

Leticia González, Juan J. Nogueira, University of Vienna, Austria, and Martina De Vetta, University of Vienna and Universidad Autónoma de Madrid, Spain, have investigated the intermolecular interactions between the photosensitizer Temoporfin and a liposome using molecular dynamics (MD) simulations with a resolution down to single atoms.

The drug participates in a hydrogen-bond network with the phospholipids of the liposome. This reduces the mobility of the lipids and enhances the vesicle's loading capacity. According to the researchers, the same interactions are also expected to modify the delivery of the drug into the cell membrane of a tumor cell. Further simulations of this process and of the initial interaction between light and Temoporfin, which initiates the cytotoxic mechanism, are in progress.


Article Views: 1115

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH